ClinicalTrials.Veeva

Menu

Factors Influencing the Abortion Interval of Second-trimester Termination of Pregnancy Using Misoprostol

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

Labor Induction

Study type

Observational

Funder types

Other

Identifiers

NCT01927822
102096-F

Details and patient eligibility

About

This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Full description

Misoprostol is the primary drug of choice for medical termination. It is not only cheap, but also stable at room temperature and easily available worldwide. It is indicated for the treatment of gastritis, but is widely used off-label for a variety of indications in the practice of obstetrics and gynecology, including medication abortion, induction of labor, and the treatment of postpartum hemorrhage. The optimal dosage and route of administration have not been well defined and vary with physicians. The potency of misoprostol's effect varies with dosage, route of administration and dosing interval; both maternal and fetal factors may, to certain extent, affect the abortion interval. This study aims to analyze the factors influencing the abortion interval of second-trimester termination of pregnancy using misoprostol.

Enrollment

101 patients

Sex

Female

Ages

13 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1.All female patients who were admitted for medical termination of second-trimester pregnancy

Exclusion criteria

  1. Patients who are allergy to Cytotec.

Trial design

101 participants in 1 patient group

Pregnancy
Description:
Women who underwent termination of pregnancy at second trimester due to a variety of causes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems